Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital

Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital

BackgroundIn the context of personalized medicine, screening patients to identify targetable molecular alterations is essential for therapeutic decisions such as inclusion in clinical trials, early access to therapies, or compassionate treatment. The objective of this study was to determine the real...

Full description

Bibliographic Details
Main Authors: Sandra Pinet, Stéphanie Durand, Alexandre Perani, Léa Darnaud, Fifame Amadjikpe, Mathieu Yon, Tiffany Darbas, Alain Vergnenegre, Thomas Egenod, Yannick Simonneau, Valérie Le Brun-Ly, Julia Pestre, Laurence Venat, Frédéric Thuillier, Alain Chaunavel, Mathilde Duchesne, Véronique Fermeaux, Anne Guyot, Sylvain Lacorre, Barbara Bessette, Fabrice Lalloué, Karine Durand, Elise Deluche
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
cancer
FoundationOne CDx
next-generation sequencing
liquid biopsy
targeted therapy
precision oncology
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1104659/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1104659/full

Similar Items